Dr. Oz Jumps In as Drug Executive Collapses During Oval Office Press Conference
WASHINGTON — A dramatic moment unfolded Thursday in the Oval Office when a drug company executive fainted during a live press event. President Donald Trump was in the middle of announcing a major deal with pharmaceutical companies to lower the cost of obesity drugs when the incident occurred.
Incident During Announcement
The event, focused on a pricing agreement with Eli Lilly and Novo Nordisk, was briefly halted when Gordon Findlay, Novo Nordisk’s global brand director, suddenly collapsed. The agreement aimed to expand access and reduce prices for popular obesity treatments Zepbound and Wegovy.
Immediate Response
David Ricks, CEO of Eli Lilly, had been speaking when he noticed the emergency. He turned and asked:
“Are you okay? Gordon, are you okay?”
As Findlay fell to his knees, Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, quickly assisted him. President Trump and others present watched with concern as aides and medical personnel responded.
Aftermath and Health Update
The press were ushered from the room while the situation was handled. The Health and Human Services Secretary was also present during the interruption. Roughly thirty minutes later, when the conference resumed, President Trump provided an update, saying the executive was recovering and in stable condition.
Summary
Dr. Mehmet Oz swiftly assisted Novo Nordisk’s Gordon Findlay after he collapsed during President Trump’s Oval Office announcement about lowering drug prices.